70 related articles for article (PubMed ID: 22985603)
21. Aged garlic extract inhibits platelet activation by increasing intracellular cAMP and reducing the interaction of GPIIb/IIIa receptor with fibrinogen.
Allison GL; Lowe GM; Rahman K
Life Sci; 2012 Dec; 91(25-26):1275-80. PubMed ID: 23069586
[TBL] [Abstract][Full Text] [Related]
22. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
23. Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Frojmovic MM; Wong T; Searcy GP
Thromb Haemost; 1996 Dec; 76(6):1047-52. PubMed ID: 8972030
[TBL] [Abstract][Full Text] [Related]
24. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
25. Normal ADP-induced aggregation and absence of dissociation of the membrane GP IIb-IIIa complex of intact rat platelets pretreated with EDTA.
Gachet C; Stierlé A; Ohlmann P; Lanza F; Hanau D; Cazenave JP
Thromb Haemost; 1991 Aug; 66(2):246-53. PubMed ID: 1771618
[TBL] [Abstract][Full Text] [Related]
26. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
Xiao Z; Théroux P; Frojmovic M
Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
[TBL] [Abstract][Full Text] [Related]
27. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute.
Okamura Y; Takeoka S; Eto K; Maekawa I; Fujie T; Maruyama H; Ikeda Y; Handa M
J Thromb Haemost; 2009 Mar; 7(3):470-7. PubMed ID: 19143920
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
Mousa SA; Bozarth JM; Lorelli W; Forsythe MS; Thoolen MJ; Slee AM; Reilly TM; Friedman PA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1277-84. PubMed ID: 9732389
[TBL] [Abstract][Full Text] [Related]
29. Molecular interaction studies of hemostasis: fibrinogen ligand-human platelet receptor interactions.
Lee I; Marchant RE
Ultramicroscopy; 2003; 97(1-4):341-52. PubMed ID: 12801687
[TBL] [Abstract][Full Text] [Related]
30. Interaction of platelets with liposomes containing dodecapeptide sequence from fibrinogen.
Nishiya T; Toma C
Thromb Haemost; 2004 Jun; 91(6):1158-67. PubMed ID: 15175803
[TBL] [Abstract][Full Text] [Related]
31. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
[TBL] [Abstract][Full Text] [Related]
32. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
33. Fibrinogen γ-Chain Peptide-Coated Adenosine 5' Diphosphate-Encapsulated Liposomes Rescue Mice From Lethal Blast Lung Injury via Adenosine Signaling.
Hagisawa K; Kinoshita M; Miyawaki H; Sato S; Miyazaki H; Takeoka S; Suzuki H; Iwaya K; Seki S; Shono S; Saitoh D; Nishida Y; Handa M
Crit Care Med; 2016 Sep; 44(9):e827-37. PubMed ID: 27054893
[TBL] [Abstract][Full Text] [Related]
34. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
35. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again.
Armstrong PC; Peter K
Thromb Haemost; 2012 May; 107(5):808-14. PubMed ID: 22370973
[TBL] [Abstract][Full Text] [Related]
36. The residues AGDV of recombinant gamma chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation.
Hettasch JM; Bolyard MG; Lord ST
Thromb Haemost; 1992 Dec; 68(6):701-6. PubMed ID: 1287885
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy.
Ishida O; Hagisawa K; Yamanaka N; Tsutsumi K; Suzuki H; Takikawa M; Takeoka S; Kinoshita M
Sci Rep; 2020 Jul; 10(1):11308. PubMed ID: 32647296
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Properties of Single and Repeated Injection of Liposomal Platelet Substitute in a Rat Model of Red Blood Cell Transfusion-Induced Dilutional Thrombocytopenia.
Hashimoto M; Taguchi K; Ogaki S; Watanabe H; Kinoshita M; Nishikawa K; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
J Pharm Sci; 2015 Nov; 104(11):3968-3976. PubMed ID: 26249543
[TBL] [Abstract][Full Text] [Related]
39. Treatment with fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia.
Hagisawa K; Nishikawa K; Yanagawa R; Kinoshita M; Doi M; Suzuki H; Iwaya K; Saitoh D; Seki S; Takeoka S; Handa M; Nishida Y
Transfusion; 2015 Feb; 55(2):314-25. PubMed ID: 25145766
[TBL] [Abstract][Full Text] [Related]
40. Heptapeptide-based modification leading to enhancing the action of MTCA on activated platelets, P-selectin, GPIIb/IIIa.
Li Z; Huang F; Wu J; Gui L; Zhang X; Wang Y; Zhao S; Wang X; Peng S; Zhao M
Future Med Chem; 2018 Aug; 10(16):1957-1970. PubMed ID: 29973078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
